Clinical trial
Investigating Glycated Albumin Use for Short-Term and Additional/Alternate Monitoring of Blood Glucose Control
NCT07777900 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigating Glycated Albumin Use for Short-Term and Additional/Alternate Monitoring of Blood Glucose Control
- Lead sponsor
- Washington University School of Medicine
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- July 7, 2025
- Completion date
- December 30, 2027
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes